Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000272558 encodes a long non-coding RNA transcript that runs antisense to the TRIM38 locus[1][5]. Antisense lncRNAs are pervasively transcribed in mammalian genomes and function by various mechanisms, such as forming RNA-RNA duplexes, modulating splicing, regulating mRNA stability, or affecting epigenetic chromatin states[3][4]. However, there is no published evidence detailing the specific function, disease relevance, or regulatory effects for this antisense transcript in relation to TRIM38 or any biological process. It is not considered a canonical therapeutic target. This annotation is generic for genome-wide transcriptome reference and does not reflect a well-studied molecular entity, pathway, or drug target. Most information about antisense lncRNAs comes from general studies of natural antisense transcripts rather than any unique characterization for ENSG00000272558[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to TRIM38.